MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Long-latency somatosensory evoked potentials of the subthalamic nucleus

    C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

    Objective: This study aims to clarify the role of the STN, previously suggested as an integrative component in the control of the basal ganglia-thalamocortical circuit,…
  • 2016 International Congress

    Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

    G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)

    Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…
  • 2016 International Congress

    EEG Spectral power changes prior to non-epileptic seizures: A pilot study

    A.M. Meppelink, I. Parees, M. Beudel, S. Little, M. Edwards (Groningen, Netherlands)

    Objective: To assess possible EEG spectral power changes prior to psychogenic non-epileptic seizures (PNES) and identify whether a “positive marker” of PNES may exist. Background:…
  • 2016 International Congress

    Loss of heart rate variability in ALS: Time and frequency domain assessment

    P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

    Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…
  • 2016 International Congress

    Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up

    M.T. Montojo, Y. Macias, M. ÁLvarez, C. Martín, L. Borrega, L. Vela (Alcorcón, Spain)

    Objective: To describe the number and reasons of the visits to the emergency room (ER) and the hospitalizations of Parkinson's disease (PD) patients for a…
  • 2016 International Congress

    The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2

    F.S. Akhmedova, M.K.U. Tukhtamishev (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2 diabetes with different glucose tolerance and the influence of the…
  • 2016 International Congress

    Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

    P.C. Bhatt, V. Kumar (New Delhi, India)

    Objective: To prepare and evaluate the nanoherbaceutical formulation containing natural L-DOPA from Mucuna pruriens against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinson's disease (PD). Background: PD is…
  • 2016 International Congress

    The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

    M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

    Objective: To evaluate the role of proprioceptive processing on the gait parameters of different subtypes of Parkinson's disease. Background: Two major subtypes are considered in…
  • 2016 International Congress

    Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

    S.H. Guptha (Peterborough, United Kingdom)

    Objective: To assess whether the prevalence of osteoporosis increases with the duration of levodopa treatment in patients with Parkinson's disease. Background: Patients with Parkinson's disease…
  • 2016 International Congress

    Predictive validity of statistical models of Parkinson’s disease progression

    A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)

    Objective: To develop statistical models of Parkinson's disease (PD) progression based on a transversal assessment and to explore its predictive value in a three-year follow-up.…
  • « Previous Page
  • 1
  • …
  • 1699
  • 1700
  • 1701
  • 1702
  • 1703
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • #28953 (not found)
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley